Clinical trials
Recruiting Lung Neoplasms trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 1 |
| Apollomics Inc. | 1 |
| ArriVent BioPharma, Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Hoffmann-La Roche | 1 |
| Inhibrx Biosciences, Inc | 1 |
| Iovance Biotherapeutics, Inc. | 1 |
| National Cancer Centre, Singapore | 1 |
| National University Hospital, Singapore | 1 |
| Nuvalent Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 14 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Bronchial Neoplasms | 3 |
| Carcinoma | 3 |
| Head and Neck Neoplasms | 3 |
| Lung Diseases | 3 |
| Neoplasms | 3 |
| Colonic Neoplasms | 2 |
| Neoplasms by Histologic Type | 2 |
| Neoplasms by Site | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.